Bridging the Chasm in Ventricular Tachycardia: Medtronic’s Sphere-9 FDA Breakthrough Designation episode artwork

EPISODE · May 18, 2026 · 1 MIN

Bridging the Chasm in Ventricular Tachycardia: Medtronic’s Sphere-9 FDA Breakthrough Designation

from TheBrief.Health · host TheBrief.Health

Medtronic’s Sphere-9 catheter earned FDA Breakthrough status for ventricular tachycardia, combining RF and pulsed-field ablation to improve lesion durability, procedural safety, and recurrence outcomes significantly.

Episode metadata supplied by the publisher feed · Published May 18, 2026

Embed this episode

NOW PLAYING

Bridging the Chasm in Ventricular Tachycardia: Medtronic’s Sphere-9 FDA Breakthrough Designation

0:00 1:45

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on May 18, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!